Abstract:Our previous research has shown that lanostane triterpenoids from Ganoderma applanatum exhibit significant anti-adipogenesis effects. In order to obtain more structurally diverse lanostane triterpenoids to establish a structure–activity relationship, we continued the study of lanostane triterpenoids from the fruiting bodies of G. applanatum, and forty highly oxygenated lanostane-type triterpenoinds (1–40), including sixteen new compounds (1–16), were isolated. Their structures were elucidated using NMR spectra, X-ray crystallographic analysis, and Mosher’s method. In addition, some of their parts were evaluated to determine their anti-adipogenesis activities in the 3T3-L1 cell model. The results showed that compounds 16, 22, 28, and 32 exhibited stronger anti-adipogenesis effects than the positive control (LiCl, 20 mM) at the concentration of 20 μM. Compounds 15 and 20 could significantly reduce the lipid accumulation during the differentiation process of 3T3-L1 cells, comparable to the untreated group. Their IC50 values were 6.42 and 5.39 μM, respectively. The combined results of our previous and present studies allow us to establish a structure-activity relationship of lanostane triterpenoids, indicating that the A-seco-23→26 lactone skeleton could play a key role in anti-adipogenesis activity.

Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH

Lanostane triterpenoids from Ganoderma lucidum and their inhibitory effects against FAAH

Nor-triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH

Lanostane Triterpenoids from the Fruiting Bodies of Fomes Officinalis and Their Anti-Inflammatory Activities

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Triterpenoids with neurotrophic activity from Ganoderma lucidum.

Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum

Triterpenes from antler-shaped fruiting body of Ganoderma lucidum and their hepatoprotective activities

Cytotoxic lanostanoid triterpenes from Ganoderma lucidum.

Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Ganoderterpene A, a New Triterpenoid from Ganoderma Lucidum, Attenuates LPS-Induced Inflammation and Apoptosis Via Suppressing MAPK and TLR-4/NF-κB Pathways in BV-2 Cells.

Lanostanoids isolated from Ganoderma lucidum mycelium cultured by submerged fermentation

Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense.

Anti-Adipogenic Lanostane-Type Triterpenoids from the Edible and Medicinal Mushroom Ganoderma applanatum

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi